Home › Kanser sa Suso › Texas › Austin
Pag-aaral pangklinika para sa Kanser sa Suso sa Austin, TX
Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Next Oncology Austin, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- NEXT Oncology - Austin, Austin
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Texas Oncology, Austin
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Nagre-recruitPhase 3
- Texas Oncology Central/South, Austin
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Austin, Austin
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Nagre-recruitPhase 2/3
- Texas Oncology - Central/South Texas, Austin
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Nagre-recruitPhase 3
- Texas Oncology - Austin, Austin
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
- Texas Oncology - Central / South Texas, Austin
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Nagre-recruitPhase 1/2
- Texas Oncology - Central/South, Austin
Cancer Pain Management Using a Web-based Intervention
Nagre-recruit
- The University of Texas at Austin, Austin
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Nagre-recruitPhase 3
- Texas Oncology - Central South (Balcones Dr), Austin
- Texas Oncology - Central South (James Casey), Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
- NEXT Oncology Austin, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Elligo Health Research, Inc., Austin
Sample Collection for Ongoing Research and Product Evaluation Study
Nagre-recruitObservasyonal na pag-aaral
- Natera, Inc., Austin
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #4, Austin
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Nagre-recruitObservasyonal na pag-aaral
- Texas Oncology - Austin, Austin
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Nagre-recruitPhase 2
- Texas Oncology PA (Austin), Austin
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY134 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA111 pag-aaral
- Nashville, TN80 pag-aaral
- Los Angeles, CA72 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Durham, NC63 pag-aaral
- Queens, NY63 pag-aaral
- Chicago, IL58 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Austin
- Non-Small Cell Lung Cancer30 pag-aaral
- Kanser (lahat ng uri)20 pag-aaral
- Obesity20 pag-aaral
- Metastatic Cancer19 pag-aaral
- Colorectal Cancer19 pag-aaral
- Pagkabigo ng Puso18 pag-aaral
- Overweight18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Kanser ng Endometrium15 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Depression14 pag-aaral
- Triple-Negative Breast Cancer13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.